About 1 in every 10 children and teens in the U.S. has a food allergy, an abnormal immune response to a specific food. That's roughly two kids per classroom. Food allergies have risen by 50% since ...

Spring is just around the corner, which means you should already be taking your usual seasonal allergy medicines, experts say ...

There are few things worse than falling into a deep sleep only to find yourself awake and staring at the ceiling at 2 a.m.

Add Yahoo as a preferred source to see more of our stories on Google. When equine herpesvirus-1 (EHV-1) swept through a Texas barrel racing event in November 2025, the consequences extended well ...

Experimental research suggests matcha tea may reduce sneezing in allergic rhinitis by suppressing neuronal activation involved in the sneezing reflex.

Mold in the home can cause a wide range of health issues—from mild allergies to serious chronic conditions—yet it often goes undetected. Experts say understanding the risks and how to identify mold is ...

Drs. Jessa Miller and Amrita Ray discuss the paradox of increasing incidence and decreasing mortality in AIFRS.

U.S. Immigration and Customs Enforcement is terminating the contractor running its largest detention facility and putting in charge another firm tasked with improving medical care and other ...

A repurposed epilepsy drug called sultiame cut breathing interruptions during sleep by up to 50% in adults with moderate-to-severe obstructive sleep apnea, according to results from a major European ...

GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has expanded the approved age indication of AREXVY (Respiratory Syncytial Virus Vaccine, Adjuvanted) to adults ...

TONMYA (cyclobenzaprine HCl sublingual tablets) launched November 17, 2025, for the treatment of fibromyalgia; through February 27, 2026, more than 1,500 healthcare providers have prescribed TONMYA to ...